Sernova Biotherapeutics (OTCMKTS:SEOVF) Releases Earnings Results

Sernova Biotherapeutics (OTCMKTS:SEOVF) announced its quarterly earnings data on Friday. The company reported ($0.01) EPS for the quarter, Zacks reports.

Sernova Biotherapeutics Price Performance

Shares of SEOVF stock traded down $0.00 during mid-day trading on Friday, hitting $0.09. The company had a trading volume of 33,000 shares, compared to its average volume of 27,487. The company has a market capitalization of $31.37 million, a P/E ratio of -2.37 and a beta of 1.08. The stock’s 50 day moving average price is $0.11 and its 200-day moving average price is $0.12. Sernova Biotherapeutics has a 52-week low of $0.09 and a 52-week high of $0.18.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.